Heartflow Inc. (HTFL)
NASDAQ: HTFLHealthcareHealth Information ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
HTFL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $4.29B
- EPS (TTM)
- -$0.23
- Dividend yield
- None
- 52-week range
- 20.13 – 54.32
- Day range
- 48.44 – 51.50
- Volume / Avg
- 1.44M / 1.79M
- Beta
- —
- Shares outstanding
- 86.95M
52-week range
HTFL stock today
Shares of Heartflow (HTFL) finished lower on Oct 7 at $49.36, a drop of 2.62% or $1.33 per share, versus the S&P 500's 0.22% decline. At this level, HTFL sits near the top of its 52-week range of $20.13 to $54.32: 9.1% below the high, set on Oct 6, 2026 and 145.2% above the low. HTFL is up 69.3% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 41.1%.
Heartflow has posted a net loss over the last twelve months (EPS of -$0.23), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Heartflow
Company profileHeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies.
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Mr. John C.M. Farquhar
- Headquarters
- San Francisco, CA
- Employees
- 843
- IPO year
- 2025
- Website
- heartflow.com
Financial highlights
Full financialsIn fiscal 2025, Heartflow generated $176.0 million in revenue, up 39.9% from fiscal 2024, its 2nd consecutive year of revenue growth. Heartflow reported a net loss of $116.8 million, compared with a loss of $96.4 million a year earlier. Gross margin was 76.8% (up from 75.1%) and operating margin -36.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $176.03M | $125.81M | $87.17M |
| Growth | +39.92% | +44.32% | — |
| Net income | $-116.79M | $-96.43M | $-95.66M |
| EPS (diluted) | $-3.17 | $-17.98 | $-25.32 |
Analyst forecast
ForecastConsensus (10 analysts)
none
Avg. price target
$46.00-6.81%
- Strong buy 2
- Buy 6
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Q2 2026)
- Aug 13, 2026
- EPS actual vs est.
- $-0.18 vs —
HTFL news
All HTFL newsHeartflow peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CERTCertara Inc. | 8.96 | -3.34% | $1.37B | vs HTFL |
| OMDAOmada Health Inc. | 20.89 | +0.77% | $1.28B | vs HTFL |
| GDRXGoodRx Holdings Inc. Class A | 3.25 | -0.61% | $1.11B | vs HTFL |
| TDOCTeladoc Health Inc. | 5.56 | -3.64% | $1.01B | vs HTFL |
| HQYHealthEquity Inc. | 91.90 | +0.93% | $7.60B | vs HTFL |
| HSTMHealthStream Inc. | 32.10 | +2.52% | $982.13M | vs HTFL |
| PHRPhreesia Inc. | 10.50 | +2.44% | $651.74M | vs HTFL |
| SOPHSOPHiA GENETICS SA | 7.15 | -3.12% | $608.66M | vs HTFL |
Indexes, lists and sector
Appears in lists
Heartflow stock FAQ
What is Heartflow's stock price today?
HTFL last traded at $49.36 as of Oct 7, 4:00 PM EDT, down 2.62% on the day. Prices are delayed at least 15 minutes.
Who is Heartflow's CEO?
Mr. John C.M. Farquhar is the chief executive officer of Heartflow Inc., which has about 843 employees.
What is the HTFL 52-week high?
The 52-week high for HTFL is $54.32 and the 52-week low is $20.13. The stock is currently 9.1% below its high.